tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
PremiumThe FlyDrugmakers set to make deals with Trump in exchange for incentives, WaPo reports
10d ago
Evaxion provides update on MSD collaboration, retains rights of EVX-B2
Premium
The Fly
Evaxion provides update on MSD collaboration, retains rights of EVX-B2
10d ago
Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says
Premium
The Fly
Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says
10d ago
Merck: Undervalued Buy with Robust Pipeline and Diversified Post‑Keytruda Revenue Strategy
PremiumRatingsMerck: Undervalued Buy with Robust Pipeline and Diversified Post‑Keytruda Revenue Strategy
12d ago
FDA aims to fast track two Merck drugs with high sales potential, Reuters says
Premium
The Fly
FDA aims to fast track two Merck drugs with high sales potential, Reuters says
12d ago
Merck reports ‘positive’ results from Phase 3 KEYNOTE-B15 trial
Premium
The Fly
Merck reports ‘positive’ results from Phase 3 KEYNOTE-B15 trial
12d ago
Merck price target raised to $120 from $105 at BofA
PremiumThe FlyMerck price target raised to $120 from $105 at BofA
14d ago
Merck & Company: Strong Growth Potential Amidst Robust Pipeline and Strategic Product Launches
Premium
Ratings
Merck & Company: Strong Growth Potential Amidst Robust Pipeline and Strategic Product Launches
14d ago
Mixed options sentiment in Merck with shares up 0.71%
Premium
The Fly
Mixed options sentiment in Merck with shares up 0.71%
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100